Navigation Links
Echo Therapeutics Announces 2010 Financial Results
Date:3/21/2011

FRANKLIN, Mass., March 21, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.  Echo's Annual Report on Form 10-K is available through Echo's website at www.echotx.com.

Corporate Highlights:

  • In February 2010, Echo Therapeutics, Inc. announced an additional advance in the product design of Symphony with the development of its next generation electronic component package. This important advance included an initial 33% reduction in component size and improved architectural design as compared to the prototype electronic package of the Company's earlier Symphony tCGM device.
  • Echo Therapeutics' needle-free Symphony tCGM System was profiled in a March 31, 2010 online article in Scientific American Magazine entitled "This Really Won't Hurt a Bit: Wireless Sensor Promises Diabetics Noninvasive Blood Sugar Readings," which discusses the importance of continuous glucose monitoring.  Another article, "Echo Therapeutics' Needle-Free Symphony Continuous Glucose Monitoring System," was featured in the November 29, 2010 issue of Diabetes Health Magazine.
  • In August 2010, following final product development work of the Prelude SkinPrep System, Echo Therap
    '/>"/>

  • SOURCE Echo Therapeutics, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
    3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
    4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
    6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
    7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
    8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
    9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
    10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
    11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2014)... 2014  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced today that Sergio Traversa , chief ... MICRO "MAIN Event" Micro-Cap Growth Conference on Wednesday, December ... Luxe Sunset Bel Air Hotel, which is located at ... . The presentation is scheduled for ...
    (Date:11/24/2014)... , Nov. 24, 2014  AiCure, an artificial ... technology to monitor medication ingestion, has announced the ... and intervene with patients receiving medication as maintenance ... overdoses from prescription opiates have quadrupled in the ... per year than heroin, cocaine and benzodiazepines combined. ...
    (Date:11/24/2014)... 24, 2014  GlySens Incorporated announced today that it ... from the National Institute of Diabetes and Digestive and ... of Health (NIH).  The grant is intended to support ... long term implantable glucose monitoring system.  Final preparations for ... expected to begin before the end of 2014. ...
    Breaking Medicine Technology:Relmada Therapeutics To Present At LD MICRO Conference 2Can artificial intelligence solve the $55 billion problem of opioid abuse? 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2
    ... --  Empire Genomics today announced that it has ... portfolio for the Japanese market.  The deal represents Empire,s international ... "We are excited to have such a proven and expert ... access to our broad genomic product and service portfolio," said ...
    ... MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. ... Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ... mg, 15 mg, and 20 mg. This product is the ... which is indicated for the treatment of schizophrenia and the ...
    Cached Medicine Technology:Empire Genomics Chooses Funakoshi as Japan Distributor 2Mylan Launches Generic Version of Zyprexa® Tablets 2
    (Date:11/24/2014)... 2014 Gersowitz Libo & Korek, P.C., a ... national Tier recognition in the 2015 Edition of U.S. News-Best ... signals a unique combination of quality law practice and breadth ... this honor and especially grateful to our clients whose continued ... ranking possible,” said Jeff S. Korek, senior partner at ...
    (Date:11/23/2014)... a well-known wedding dress manufacturer, has unveiled its new collection ... now offered at deeply discounted prices, up to 75 percent ... 15. The main purpose of the promotion is to expand ... are ideal options for ladies who are eager to look ... new mint cocktail dresses are very beautiful; they are made ...
    (Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water ... providing an 8 year warranty on its selected hot water ... up due to the impending winter season, it was important ... premium service that the company provides. As a result, Pro ... Wood and Bradford hot water tanks. , “Every installer ...
    (Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, has released a ... are available at low rates up to 30% off. ... new emergency doors. The emergency door adopts fireproof material ... several colors. All of the products are top-quality guaranteed. ... not as easy as many people think. As ...
    (Date:11/23/2014)... (PRWEB) November 23, 2014 More than ... month in a federal litigation involving Byetta lawsuits ( ... medications, Bernstein Liebhard LLP reports. , A Case ... over a class of Type 2 diabetes medications referred ... the U.S. District Court, Southern District of California, where ...
    Breaking Medicine News(10 mins):Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
    ... President, Corporate Development and, Senior Vice ... N.J., Sept. 11 Pharmacopeia,(Nasdaq: PCOP ), ... novel,small molecule therapeutics, today announced the appointments of ... and S. David,Kimball, Ph.D., as Senior Vice President, ...
    ... 11 Vista Partners announced today,that it has ... ).,Ross Silver, Director of Research for Vista Partners ... I trials. We were,particularly encouraged by activity in ... been approved for use in this difficult to ...
    ... XI,AN, China, Sept. 11 /Xinhua-PRNewswire-FirstCall/ -- China,Bionanometer Industries ... the bionanometer industry, has recently promoted a new,series ... a year of scientific verification, research and experiments. ... dream, and therefore the product,line,s name means -- ...
    ... Health Card Systems, Inc. (Nasdaq: NMHC ), a ... for the fiscal,fourth quarter and fiscal year ended June ... Revenue for the 2007 fiscal fourth quarter was ... the same period last year, a 31.0,percent decrease. This ...
    ... Stop Severe Bleeding, BETHESDA, Md., Sept. 10 ... high-pressure,bleeding in moderate to severe wounds has received FDA ... good news for soldiers,and civilians alike, because the product ... spot. "The FDA,s speedy approval of WoundStat means ...
    ... Sept. 10 The Blue Cross and Blue,Shield ... Department of Health Care Policy, announced today seven ... BlueWorks(R) winners, in the,category of ,Collaborating with Providers., ... the Harvard Medical School,Department of Health Care Policy ...
    Cached Medicine News:Health News:Pharmacopeia Announces Senior Additions to Management Team 2Health News:Pharmacopeia Announces Senior Additions to Management Team 3Health News:Pharmacopeia Announces Senior Additions to Management Team 4Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 3Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 2Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 3Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 4Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 5Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 6Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 7Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 8Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 9Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 10Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 11Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 12Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 13Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 14Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 15Health News:NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results 16Health News:Life-Saving News for Battlefield Soldiers & Wounded Civilians 2Health News:Life-Saving News for Battlefield Soldiers & Wounded Civilians 3Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 2Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 3Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 4Health News:Blue Cross and Blue Shield Initiatives Recognized for Increasing Patient Safety and Efficiency 5
    ... spill-proof design and effective output, even when ... medical nebulizers are free-standing for easy preparation., ... available., ,All Portex® medication nebulizer products ... feature consistently fine misting and the efficient ...
    ... closed dilution nebulizer allows the clinician to deliver ... gas into the side port for precise high ... P31000N, for normal flow patients, delivers 8-12 lpm ... the side port. For your high flow needs, ...
    ... For use with metered dose inhalers., ... aerosolized medication from MDI canisters. Its versatile ... a ventilator circuit, in conjunction with an ... routine, oral inhalation. ACE may also be ...
    Rotary Piston Mini Nebulizer...
    Medicine Products: